Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Metalloproteinase from Staphylococcus aureus | A metalloproteinase, or metalloprotease, is any protease enzyme whose catalytic mechanism involves a metal. An example of this would be meltrin which plays a significant role in the fusion of muscle cells during embryo development, in a process known as myogenesis. Most metalloproteases require zinc, but some use cobalt. The metal ion is coordinated to the protein via three ligands. The ligands co-ordinating the metal ion can vary with histidine, glutamate, aspartate, lysine, and arginine. The fourth coordination position is taken up by a labile water molecule. Treatment with chelating agents such as EDTA leads to complete inactivation. EDTA is a metal chelator that rem...tial for activity. They are also inhibited by the chelator orthophenanthroline. Applications: Enzyme used for structural and enzymological studies. specificity similar to that of thermolysin with preference to hydrophobic p1' residues. Group: Enzymes. Synonyms: Aureolysin. Enzyme Commission Number: EC 3.4.24.29. CAS No. 39335-13-2. Purity: > 95 % (SDS-PAGE). Metalloproteinase. Mole weight: 28000. Storage: at -15 °C to -25 °C. Form: Lyophilized from 20 mM Tris/HCl pH 7.8, containing 5-10 mM CaCl2. Source: Staphylococcus aureus. Aureolysin; EC 3.4.24.29; Metalloproteinase; Staphylococcus aureus neutral proteinase; Staphylococcus aureus neutral protease. Cat No: NATE-1617. |  |
| Anti-Matrix Metalloproteinase-11, N-Terminal antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. |  |
| Anti-Matrix Metalloproteinase-12, Propeptide Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-14, N-Terminal antibody produced in rabbit | 0.5 mg/mL, affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-15, Hinge Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-18, C-Terminal antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-18 Hinge Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-18, N-Terminal antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-19, Hinge Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-19, N-Terminal antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-19, Propeptide Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-1 antibody produced in goat | affinity isolated antibody, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-21, C-Terminal antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-21, Hinge Region antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-21, N-Terminal antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-21, Propeptide Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-22, C-Terminal antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-22, Hinge Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-22, N-Terminal antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-22, Propeptide Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-23, C-Terminal antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-23, Hinge Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-24, Cytoplasmic antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-24, Hinge Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-24, Propeptide Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-25, C-Terminal antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-25, Hinge Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-25, Propeptide Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-26, Hinge Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-26, N-Terminal Active antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-26, Propeptide Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-27, C-Terminal antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-27, Hinge Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-27, N-Terminal antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-27, Propeptide Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-28, Propeptide Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-2 antibody produced in rabbit | ~1 mg/mL, IgG fraction of antiserum, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-3, Propeptide Region antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-7, N-Terminal of Catalytic Zinc Site antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-9 antibody produced in goat | affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Matrix Metalloproteinase-9, C-Terminal antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Tissue Inhibitor of Metalloproteinase-2, First Loop antibody produced in rabbit | ~1 mg/mL, buffered aqueous glycerol solution, affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Tissue Inhibitor of Metalloproteinase-2, Second Loop antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Tissue Inhibitor of Metalloproteinase-3, First Loop antibody produced in rabbit | ~1 mg/mL, buffered aqueous glycerol solution, affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Tissue Inhibitor of Metalloproteinase-4, First Loop antibody produced in rabbit | ~1 mg/mL, buffered aqueous glycerol solution, affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Tissue Inhibitor of Metalloproteinase-4, Second Loop antibody produced in rabbit | ~1 mg/mL, buffered aqueous glycerol solution, affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Tissue Inhibitor of Metalloproteinase-4, Third Loop antibody produced in rabbit | ~1 mg/mL, buffered aqueous glycerol solution, affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Matrix Metalloproteinase-12, Catalytic Domain human | recombinant, expressed in E. coli, ?95% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Matrix Metalloproteinase-13 (HisoTag) from Human, Recombinant | Matrix metalloproteinases are members of a unique family of proteolytic enzymes that have a zinc ion at their active sites and can degrade collagens, elastin and other components of the extracellular matrix (ECM). These enzymes are present in normal healthy individuals and have been shown to have an important role in processes such as wound healing, pregnancy, and bone resorption. However, overexpression and activation of MMPs have been linked with a range of pathological processes and disease states involved in the breakdown and remodeling of the ECM. Such diseases include tumor invasion and metastasis, rheumatoid arthritis, periodontal disease and vascular pr..., a ca2+- and zn2+- binding catalytic domain, a hinge region, and a c-terminal hemopexin domain. hydrolyzes collagen type ii 5-6 times faster than collagens type i and iii. exhibits high activity towards gelatin and degrades α1-antichymotrypsin and plasminogen activator inhibitor-2. Group: Enzymes. Synonyms: Collagenase-3; Matrix metallopeptidase 13; MMP13; CLG3; MANDP1; MMP-13. Purity: >90% by SDS-PAGE. Matrix Metalloproteinase. Mole weight: 60 kDa. Activity: >50 mU/mg protein. Storage: < -70°C; Avoid freeze/thaw. Form: Liquid. Source: S. frugiperda. Species: Human. Collagenase-3; Matrix metallopeptidase 13; MMP13; CLG3; MANDP1; MMP-13. Cat No: NATE-0859. | |
| Matrix Metalloproteinase-1 from Human, Recombinant | Matrix metalloproteinases are members of a unique family of proteolytic enzymes that have a zinc ion at their active sites and can degrade collagens, elastin and other components of the extracellular matrix (ECM). These enzymes are present in normal healthy individuals and have been shown to have an important role in processes such as wound healing, pregnancy, and bone resorption. However, overexpression and activation of MMPs have been linked with a range of pathological processes and disease states involved in the breakdown and remodeling of the ECM. Such diseases include tumor invasion and metastasis, rheumatoid arthritis, periodontal disease and vascular processe...may also undergo autocatalysis to yield a 27 kda/22 kda active enzyme. expressed by a large number of cell types. cleaves fibrillar type i collagen. must be activated just prior to use. Group: Enzymes. Synonyms: Matrix Metalloproteinase 1; Human Interstitial Collagenase; Collagenase-1; EC 3.4.24.7; vertebrate collagenase. Enzyme Commission Number: EC 3.4.24.7. CAS No. 9001-12-1. Purity: >90% by SDS-PAGE. Matrix Metalloproteinase. Mole weight: 56 kDa/52 kDa. Activity: >15 mU/mg protein. Storage: < -70°C; Avoid freeze/thaw. Form: Liquid. Source: Human Rheumatoid Synovial Fibroblast. Species: Human. Matrix Metalloproteinase 1; Human Interstitial Collagenase; Collagenase | |
| Matrix Metalloproteinase-1 human | recombinant, expressed in NSO cells, >95% (SDS-PAGE), buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Matrix Metalloproteinase-2 from Human, Recombinant | Matrix metalloproteinases are members of a unique family of proteolytic enzymes that have a zinc ion at their active sites and can degrade collagens, elastin and other components of the extracellular matrix (ECM). These enzymes are present in normal healthy individuals and have been shown to have an important role in processes such as wound healing, pregnancy, and bone resorption. However, overexpression and activation of MMPs have been linked with a range of pathological processes and disease states involved in the breakdown and remodeling of the ECM. Such diseases include tumor invasion and metastasis, rheumatoid arthritis, periodontal disease and vascular processe... does not interfere with activation. may contain up to 10% timp proteins. during storage, a small portion (less than 10%) of the enzyme may also become activated. Group: Enzymes. Synonyms: 72 kDa Gelatinase; Matrix Metalloproteinase 2; Gelatinase A; EC 3.4.24.24; type IV collagenase; 3/4 collagenase; matrix metalloproteinase 5; 72 kDa gelatinase type A; collagenase IV; collagenase type IV; MMP 2; type IV collagen metalloproteinase; type IV collagenase/gelatinase. Enzyme Commission Number: EC 3.4.24.24. CAS No. 146480-35-5. Purity: >90% by SDS-PAGE. Matrix Metalloproteinase. Mole weight: 72 kDa. Storage: < -70°C; Avoid freeze/thaw. Form: Liquid. Source: CHO Cells. Spe | |
| Matrix Metalloproteinase-2 from mouse | recombinant, expressed in NSO cells, >95% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Matrix Metalloproteinase-2 human | >90% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Matrix Metalloproteinase-3 from Human, Recombinant | Matrix metalloproteinase-3 (MMP-3) also known as stromelysin-1 and transin (EC 3.4.24.17) cleaves a number of substrates including cartilage proteoglycan, collagen types II, III, IV, V and IX, fibronectin, laminin, and can activate MMP 1. MMP-3 is secreted as 57 and 59 kDa proenzymes and can be activated in vitro by organomercurials (e.g., 4 aminophenylmercuric acetate, APMA) and in vivo by proteases via intermediate forms to a 45 kDa active MMP 3 enzyme. Further autolysis to a 28 kDa form can also occur. MMP-3 is thought to play an important role in pathophysiological degradation processes associated with conditions such as rheumatoid arthritis and cancer cell invas...C 3.4.24.17; matrix metalloproteinase 3; proteoglycanase; collagenase activating protein; procollagenase activator; transin; MMP-3; neutral proteoglycanase; stromelysin; collagen-activating protein. Enzyme Commission Number: EC 3.4.24.17. CAS No. 79955-99-0. Purity: >95% by SDS-PAGE. Matrix Metalloproteinase. Mole weight: 57 kDa. Storage: < -70°C; Avoid freeze/thaw. Form: Lyophilized from 100 mM NaCl, 50 mM HEPES, pH 7.3. Species: Human. Stromelysin 1; EC 3.4.24.17; matrix metalloproteinase 3; proteoglycanase; collagenase activating protein; procollagenase activator; transin; MMP-3; neutral proteoglycanase; stromelysin; collagen-activating protein. Cat No: NATE-0861. | |
| Matrix Metalloproteinase-7 from human, Recombinant | MMP-7 degrades general matrix components and may have a role in processes such as host defense, cell proliferation, and protein turnover as well as tissue remodeling. Group: Enzymes. Synonyms: MMP7; matrix metallopeptidase 7; MMP-7; matrin; uterine metalloendopeptidase; matrix metalloproteinase 7; putative (or punctuated) metalloproteinase-1; matrix metalloproteinase pump 1; MMP 7; PUMP-1 proteinase; PUMP; metalloproteinase pump-1; putative metalloproteinase; MMP. CAS No. 141256-52-2. Matrix Metalloproteinase. Storage: -70°C. Form: buffered aqueous solution, Supplied in a buffer containing the active enzyme in 10 mM HEPES, pH 7.4, 0.15 M sodium chloride, 5 mM calcium chloride. Source: E. coli. Species: Human. MMP7; matrix metallopeptidase 7; MMP-7; matrin; uterine metalloendopeptidase; matrix metalloproteinase 7; putative (or punctuated) metalloproteinase-1; matrix metalloproteinase pump 1; MMP 7; PUMP-1 proteinase; PUMP; metalloproteinase pump-1; putative metalloproteinase; MMP. Cat No: NATE-0451. | |
| Matrix Metalloproteinase-7 human | ~0.1 mg/mL, recombinant, expressed in E. coli, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Matrix Metalloproteinase-8 from Human, Recombinant | Full-length recombinant human neutrophil pro-collagenase (MMP-8), latent form. Matrix metalloproteinase 8 (MMP-8), or neutrophil collagenase, degrades interstitial collagens, acting preferentially on collagen type I. Increased full-length MMP-8 protein was associated with infiltration into the skin of neutrophils, which are the major cell type that expresses MMP-8. MMP-8 is synthesized and stored in specific granules in neutrophil leukocytes. MMP-8 activity is therefore regulated by factors such as surface-bound ligands (IgG or complement components) that release it through degranulation.Once released and activated through proteolytic or oxidative mechanisms, MMP-8 p...ollagenase activity. Group: Enzymes. Synonyms: Neutrophil collagenase; EC 3.4.24.34; Matrix metalloproteinase-8; MMP-8; PMNL collagenase; PMNL-CL; HNC; CLG1. Enzyme Commission Number: EC 3.4.24.34. CAS No. 9001-12-1. Purity: Greater than 90% as determined by SDS-PAGE. Matrix Metalloproteinase. Mole weight: 75 kDa. Activity: 100 units/ml. Stability: MMP-8 although stable at 4°C for 1 week, should be stored desiccated below -18°C. Please prevent freeze-thaw cycles. Appearance: Sterile Filtered clear solution. Source: E. coli. Species: Human. Neutrophil collagenase; EC 3.4.24.34; Matrix metalloproteinase-8; MMP-8; PMNL collagenase; PMNL-CL; HNC; CLG1. Cat No: NATE-0862. | |
| Matrix Metalloproteinase-9 from Human, Recombinant | Matrix metalloproteinases are members of a unique family of proteolytic enzymes that have a zinc ion at their active sites and can degrade collagens, elastin and other components of the extracellular matrix (ECM). These enzymes are present in normal healthy individuals and have been shown to have an important role in processes such as wound healing, pregnancy, and bone resorption. However, overexpression and activation of MMPs have been linked with a range of pathological processes and disease states involved in the breakdown and remodeling of the ECM. Such diseases include tumor invasion and metastasis, rheumatoid arthritis, periodontal disease and vascular processe...(less than 10%) of the enzyme may also become activated. requires activation prior to use. a simple activation protocol is included. Applications: Immunoblotting (1 ug protein/lane) substrate cleavage assay (1 ug protein/lane) zymography (1 ug protein/lane). Group: Enzymes. Synonyms: Gelatinase B; EC 3.4.24.35; 92-kDa gelatinase; matrix metalloproteinase 9; type V collagenase; 92-kDa type IV collagenase; macrophage gelatinase; 95 kDa type IV collagenase/gelatinase; collagenase IV; collagenase type IV; gelatinase MMP 9; MMP 9; type IV collagen metalloproteinase. Enzyme Commission Number: EC 3.4.24.35. CAS No. 146480-36-6. Purity: >90% by SDS-PAGE. Matrix Metalloprotei | |
| Matrix Metalloproteinase-9 human | recombinant, expressed in, >90% (SDS-PAGE), buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| membrane-type matrix metalloproteinase-1 | In peptidase family M10, but, unlike most members of the family, is membrane-anchored. Believed to play an important role in the activation of progelatinase A at cell surfaces. Group: Enzymes. Synonyms: matrix metalloproteinase 14. Enzyme Commission Number: EC 3.4.24.80. CAS No. 161384-17-4. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4364; membrane-type matrix metalloproteinase-1; EC 3.4.24.80; 161384-17-4; matrix metalloproteinase 14. Cat No: EXWM-4364. | |
| Tissue Inhibitor of Metalloproteinase-1 human | recombinant, expressed in CHO cells, ~500 ?g/mL protein, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Tissue Inhibitor of Metalloproteinase-2 human | recombinant, expressed in CHO cells, >95% (SDS-PAGE), lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Tissue Inhibitor of Metalloproteinase-3 human | recombinant, expressed in NSO cells, >95% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| 11-Aminoundecanoic acid | 11-Aminoundecanoic Acid is used to prepare thapsigargin analogues targeting apoptosis to prostatic cancer cells. It is also used to synthesize N-carboxyalkylpeptides containing extended alkyl residues at P1'as matrix metalloproteinase inhibitors. Synonyms: ω-Aminoundecanoic acid; Undecanoic acid, 11-amino-; 11-Aminoundecylic acid; 11-amino-undecanoic acid; H-11-Aun-OH. Grades: ≥ 99% (Titration). CAS No. 2432-99-7. Molecular formula: C11H23NO2. Mole weight: 201.31. |  |
| 1-?Biphenyl-?4-?yl-?propan-?2-?one | 1-?Biphenyl-?4-?yl-?propan-?2-?one is a reactant used in the preparation of potent inhibitors of metalloproteinases 2 and 9 (MMP-2, MMP-9). This affects such processes such as homeostatic regulation, tumor progression, etc. Group: Biochemicals. Grades: Highly Purified. CAS No. 5333-1-7. Pack Sizes: 1g, 2.5g. Molecular Formula: C15H14O, Molecular Weight: 210.27. US Biological Life Sciences. |  Worldwide |
| 20(R)-Ginsenoside Rh2 | 20(R)-Ginsenoside Rh2, a matrix metalloproteinase (MMP) inhibitor, acts as a cell antiproliferator. It has anticancer effects via blocking cell proliferation and causing G1 phase arrest. 20(R)-Ginsenoside Rh2 induces apoptosis, and has anti-inflammatory and antioxidative activity. 20(R)-Ginsenoside Rh2 inhibits the replication and proliferation of mouse and human gammaherpesvirus 68 (MHV-68) with an IC50 of 2.77 μM for murine MHV-68. Uses: Designed for use in research and industrial production. Additional or Alternative Names: b-D-Glucopyranoside, (3b,12b,20R)-12,20-dihydroxydammar-24-en-3-yl; (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl beta-d-glucopyranoside; 20-(R)-Ginsenoside Rh2; 20(R)-Ginsenoside Rh2; 20(R)-GINSENOSIDERH2; Ginsenoside-Rh2; Ginsenoside Rh2, 20(R)-; 20(R)-Ginsenoside-Rh2; (R) Ginsenoside Rh2. Product Category: Inhibitors. Appearance: Powder. CAS No. 112246-15-8. Molecular formula: C36H62O8. Mole weight: 622.88. Purity: 0.98. IUPACName: (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol. Canonical SMILES: CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C. Product ID: ACM112246158. Alfa Chemistry ISO 9001:2015 Certified. |  |
| 20(R)-Ginsenoside Rh2-d6 | 20(R)-Ginsenoside Rh2-d6 is the labeled version of 20(R)-Ginsenoside Rh2 (G410215), which is a matrix metalloproteinase inhibitor that acts as a cell antiproliferator. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg, 2.5mg. Molecular Formula: C36H56D6O8, Molecular Weight: 628.91. US Biological Life Sciences. | Worldwide |
| 2-(4-Phenoxy-phenyl)-acetamidine Hydrochloride | 2-(4-Phenoxy-phenyl)-acetamidine hydrochloride is a derivative of 4-phenoxyphenyl acetonitri le. 4-Phenoxyphenyl acetonitri le is a reagent that is used in the preparation and inhibition of matrix metalloproteinases MMP-2, -3 and -8. Group: Biochemicals. Grades: Highly Purified. CAS No. 1172966-21-0. Pack Sizes: 100mg, 1g. Molecular Formula: C14H15ClN2O, Molecular Weight: 262.73. US Biological Life Sciences. | Worldwide |
| (2R)-TAPI-1 | TAPI-1 is a potent inhibitor of matrix metalloproteinases and TACE (TNF-α convertase/ADAM17/α-secretase). Synonyms: TAPI 1; TAPI1. Grades: >98%. CAS No. 163847-77-6. Molecular formula: C26H37N5O5. Mole weight: 499.6. | |
Our database is helping our users find suppliers everyday.
